Elie Hanania

Company: Avid Biosciences

Job title: Vice President - Process Development & Viral Vector Technologies

Seminars:

Production, Purification, & Characterization of Oncolytic Herpes Simplex Virus for Viro-Oncotherapies 4:00 pm

• Oncolytic herpes simplex virus (HSV) can be modified to target cancer cells and directly kill them as well as to activate the immune system to recognize and attack the tumor • Optimized approach for the production and purification of HSV and readiness for scale up manufacturing • Multilevel characterization of process and product supporting…Read more

day: Day One